HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideyuki Tominaga Selected Research

Amino Acid Transport Systems (Amino Acid Transporter)

12/2020Interaction of Halogenated Tyrosine/Phenylalanine Derivatives with Organic Anion Transporter 1 in the Renal Handling of Tumor Imaging Probes.
10/2016Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.
3/2016Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging.
2/2016Transport of 3-fluoro-L-α-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [(18)F]FAMT positron emission tomography.
11/2015CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
10/2015Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
9/2015Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
9/2015Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
1/2015Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.
11/2014Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideyuki Tominaga Research Topics

Disease

28Neoplasms (Cancer)
12/2020 - 07/2009
4Colorectal Neoplasms (Colorectal Cancer)
04/2014 - 01/2011
3Squamous Cell Carcinoma of Head and Neck
11/2015 - 06/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2010 - 04/2010
2Lung Neoplasms (Lung Cancer)
12/2016 - 12/2010
1Sarcoidosis (Schaumann Disease)
01/2018
1Esophageal Squamous Cell Carcinoma
10/2016
1Esophageal Neoplasms (Esophageal Cancer)
10/2016
1Inflammation (Inflammations)
03/2016
1Melanoma (Melanoma, Malignant)
10/2015
1Hepatocellular Carcinoma (Hepatoma)
09/2015
1Glioma (Gliomas)
01/2015
1Granuloma
01/2015
1Pancreatic Ductal Carcinoma
01/2015
1Multiple Myeloma
11/2014
1Colonic Neoplasms (Colon Cancer)
04/2014
1Cholangiocarcinoma
10/2013
1Lymphatic Metastasis
10/2013
1Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2013
1Adenoid Cystic Carcinoma (Cylindroma)
10/2013
1Sarcoma (Soft Tissue Sarcoma)
03/2012
1Hypoxia (Hypoxemia)
08/2010
1Breast Neoplasms (Breast Cancer)
04/2010
1Rhinitis
06/2009
1Seasonal Allergic Rhinitis (Hay Fever)
06/2009
1Chromosome Aberrations (Chromosome Abnormalities)
06/2004

Drug/Important Bio-Agent (IBA)

19Amino Acid Transport Systems (Amino Acid Transporter)IBA
12/2020 - 10/2010
7Tyrosine (L-Tyrosine)FDA Link
12/2020 - 10/2010
7Amino AcidsFDA Link
09/2015 - 08/2011
3Glucose (Dextrose)FDA LinkGeneric
10/2016 - 08/2010
3Indicators and Reagents (Reagents)IBA
11/2015 - 10/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 08/2010
3Biological ProductsIBA
10/2013 - 08/2010
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2016 - 06/2013
2Protein Isoforms (Isoforms)IBA
03/2016 - 08/2012
2Bevacizumab (Avastin)FDA Link
04/2014 - 01/2011
2AcidsIBA
10/2013 - 08/2009
2Monoclonal AntibodiesIBA
08/2012 - 04/2010
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2011 - 07/2009
1HalogensIBA
12/2020
1Organic Anion TransportersIBA
12/2020
1Large Neutral Amino Acid-Transporter 1IBA
12/2020
1Phenylalanine (L-Phenylalanine)FDA Link
12/2020
1Hydroxyl RadicalIBA
12/2020
1GlucocorticoidsIBA
01/2018
1Leucine (L-Leucine)FDA Link
04/2016
1Small Interfering RNA (siRNA)IBA
03/2016
1Fetal Proteins (Fetoprotein)IBA
09/2015
1AlbuminsIBA
09/2015
1Fluorouracil (Carac)FDA LinkGeneric
10/2013
1GemcitabineFDA Link
10/2013
1Biomarkers (Surrogate Marker)IBA
10/2013
1Cadherins (E-Cadherin)IBA
08/2012
1Yttrium-90IBA
08/2012
1Cetuximab (Erbitux)FDA Link
03/2012
1ErbB Receptors (EGF Receptor)IBA
03/2012
1Pharmaceutical PreparationsIBA
03/2012
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2011
1Messenger RNA (mRNA)IBA
12/2010
1Deoxyglucose (2 Deoxy D glucose)IBA
08/2010
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
08/2010
1Trastuzumab (Herceptin)FDA Link
04/2010
1Somatostatin Receptors (Somatostatin Receptor)IBA
08/2009
1SolutionsIBA
08/2009
1Octreotide (Sandostatin)FDA LinkGeneric
08/2009
1Alexa Fluor 750IBA
07/2009
1Hypnotics and Sedatives (Sedatives)IBA
06/2009
1Olopatadine Hydrochloride (Patanol)FDA Link
06/2009
1Histamine Antagonists (Antihistamines)IBA
06/2009
1Dihydrotachysterol (AT 10)IBA
06/2009
1Oxygen (Dioxygen)IBA
06/2004
1Phosphates (Orthophosphate)IBA
06/2004
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
06/2004

Therapy/Procedure

10Therapeutics
12/2020 - 04/2010
1Drug Therapy (Chemotherapy)
12/2016
1Intravenous Injections
08/2012
1Injections
08/2012
1Radioimmunotherapy
08/2012